Hepatitis A Virus, ABS-IgG (HAV IgG)

Code

2855

Principle

The presence of IgG anti-HAV, with a nonreactive IgM anti-HAV test result, implies past infection with hepatitis A virus (HAV) or vaccination against HAV.

Preanalytical

1 mL Serum Refrigerated

Turn Around Time

1 day

Methodology

Chemiluminescent microparticle immunoassay (CMIA)

Limitations

Specimens from patients who have received preparations of mouse monoclonal antibodies for diagnosis or therapy may contain human anti-mouse antibodies (HAMA). Specimens containing HAMA may produce anomalous values when tested.